The Cayman Islands Forensic Science Laboratory (Grand Cayman) recently received a polydrug submission that included two mottled orange tablets, which were marked with a raised Adidas logo on one side and unmarked on the reverse. The exhibit was seized by Royal Cayman Islands Police personnel in Grand Cayman. The tablets were 8.25 millimeters in diameter and 4.39 millimeters thick. Analysis of the orange tablets (approximately 244 milligrams each) by color test, GC/MS, and FTIR/ATR indicated MDMA, caffeine, procaine, N-benzylpiperazine (BZP, not confirmed) and 1-(3,4- methylenedioxyphenyl)-2-propanol (not confirmed); not quantitated but present in an approximate 28:1:69:1:1 ratio based on the TIC. This is the first submission of this mixture of drugs to the laboratory. The submission also included a folded piece of paper that contained yellow and green powder in two distinct layers. The two powders both contained BZP, 1-(3-(trifluoromethyl)phenyl)piperazine (TFMPP), 1,4-dibenzylpiperazine (not confirmed) and caffeine. The laboratory reported one unrelated follow-up submission of the same type tablet pictured above.
Send in a sample for testing
DrugsData tests all psychoactive drugs including ecstasy tablets, powders, research chemicals, novel pschoactive substances, and other drugs through our licensed laboratory. Ecstasy/Molly tablets cost $100. Recreational drug powder/crystal/blotter costs $100. Pharmaceuticals, supplements and all others cost $150 per analysis.
Should the public have access to independent analysis of the products they consume?
The vast majority of analyses of over-the-counter, prescription, and recreational drugs are performed in secret with no independent oversite or review. No other historical record, free from politically-controlled agencies, is currently available in North America nor most other parts of the world.
DrugsData, a project of Erowid Center, needs the support of professionals, students, parents, individuals with means, and small foundations for a total yearly budget of around $120,000 USD. Erowid Center's general budget and the co-pays we require fund most of this cost.